HSY
41
6
D
45
4
AFL
48
4
MUR
38
-6
EBAY
52
-2
CSX
50
-4
AIZ
63
4
CLX
50
-3
VNO
52
-4
DOW
40
-3
PEG
55
5
DRI
58
5
EQR
42
2
AVY
60
6
APD
49
4
DAL
72
2
HAL
53
-2
ABT
45
4
PCG
69
3
CCI
38
-4
HSY
41
6
D
45
4
AFL
48
4
MUR
38
-6
EBAY
52
-2
CSX
50
-4
AIZ
63
4
CLX
50
-3
VNO
52
-4
DOW
40
-3
PEG
55
5
DRI
58
5
EQR
42
2
AVY
60
6
APD
49
4
DAL
72
2
HAL
53
-2
ABT
45
4
PCG
69
3
CCI
38
-4
Financhill
Back

Astellas Pharma, Inc. Stock Predictions

Valuation Up 5,000%. Shares Now $0.85 - Still Early?

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
63

ALPMY
Astellas Pharma, Inc.

Last Price:
$13.65
Seasonality Move:
2.58%

7 Day Trial

ALL ACCESS PASS

$ 7

14K Investors Got In Earlier. You Still Can.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Astellas Pharma, Inc. Stock Forecast

  • Over the next 52 weeks, Astellas Pharma, Inc. has on average historically fallen by 0.9% based on the past 16 years of stock performance.
  • Astellas Pharma, Inc. has fallen lower in 9 of those 16 years over the subsequent 52-week period, corresponding to a historical accuracy of 56.25%
  • Is Astellas Pharma, Inc. Stock Undervalued?
    The current Astellas Pharma, Inc. [ALPMY] share price is $13.58. The Score for ALPMY is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • ALPMY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Astellas Pharma, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Astellas Pharma, Inc. has on average historically fallen by 0.9% based on the past 16 years of stock performance.

Astellas Pharma, Inc. Stock Rating

Buy
63
Astellas Pharma, Inc. (ALPMY) is a Buy

Is Astellas Pharma, Inc. overpriced?

  • Astellas Pharma, Inc. has fallen lower in 9 of those 16 years over the subsequent 52-week period, corresponding to a historical accuracy of 56.25%

Astellas Pharma, Inc. Stock Price History

Is ALPMY stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALPMY is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
OTCM
Country:
Japan
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
astellas.com

52-Week Data

52-Week High:
13.92
52-Week Low:
8.37

Prediction Charts

Market Cap:
24.3B
Price in USD:
13.58
Volume:
285.6K
Beta:
0.44

Technical Analysis

SMA50:
11.65
SMA100:
11.35
SMA200:
10.49
52-Wk Change:
34.72%

Stock Predictions

  • Is Astellas Pharma, Inc. stock public?
    Yes, Astellas Pharma, Inc. is a publicly traded company.
  • What is the Astellas Pharma, Inc. stock quote today?
    The Astellas Pharma, Inc. stock price is 13.58 USD today.
  • How to buy Astellas Pharma, Inc. stock online?
    You can buy Astellas Pharma, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-25 12.25 12.72 12.72 12.25
Nov-26 12.64 12.70 12.73 12.61
Nov-28 12.60 12.55 12.60 12.50
Dec-1 12.69 12.72 12.99 12.67
Dec-2 12.82 12.80 12.99 12.77
Dec-3 12.72 12.73 12.73 12.62
Dec-4 13.00 12.74 13.00 12.70
Dec-5 12.82 12.88 12.90 12.82
Dec-8 12.86 12.78 12.87 12.78
Dec-9 12.90 12.88 12.94 12.83
Dec-10 13.22 13.24 13.30 13.00
Dec-11 13.19 13.21 13.27 13.17
Dec-12 13.69 13.08 13.69 13.00
Dec-15 13.92 13.58 13.92 13.49

Astellas Pharma, Inc. Earnings

Data Unavailable

Astellas Pharma, Inc. Forecast Revenue Growth

Data Unavailable

* Astellas Pharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.